PSAs available in English and Spanish urge people to get checked for early signs of macular degeneration and glaucoma, leading causes of blindness affecting 24 million Americans.
CLARKSBURG, Md., Sept. 17, 2025–BrightFocus Foundation today launched two new national public service announcements, Stop AMD and Stop Glaucoma, to raise awareness of macular degeneration and glaucoma, leading causes of irreversible blindness among people age 50 and older in the U.S.
“These PSAs urge viewers to make vision a key part of their overall health,” said BrightFocus President and CEO Stacy Pagos Haller. “Sight-stealing diseases like age-related macular degeneration (AMD) and glaucoma can strike without warning—often showing no early symptoms or pain to indicate something is wrong. That’s why early detection and treatment are essential to protecting sight.”
Most Americans aren’t visiting an eye doctor as often as they should to catch the early signs of diseases like macular degeneration and glaucoma. These and other serious vision conditions can only be detected through a comprehensive, dilated eye exam—yet just half of people at high risk for vision loss visit an eye doctor every year.1 As many as half of those with the diseases may not even know they have them until permanent vision loss has already occurred.
The campaign features first-person stories from six individuals living with macular degeneration and glaucoma, encouraging others to take charge of their eye health through regular eye exams. In addition to the TV, radio, and print spots, the campaign also includes short videos highlighting each participant’s unique journey, showcasing the many ways these diseases can affect vision.
Nearly 20 million U.S. adults have macular degeneration, which causes vision loss in the central part of the retina, called the macula. Age is the most significant risk factor, which is why it is often called age-related macular degeneration (AMD). AMD is most common in non-Hispanic white adults, women, people over age 60, and those with a family history.
More than four million Americans are living with glaucoma, a group of eye disorders that have few symptoms in their early stages but eventually damage the optic nerve, leading to vision loss or complete blindness. Blacks and Latinos are at higher risk of glaucoma, with Black individuals at least four times as likely to have glaucoma as white individuals. Open-angle glaucoma is the leading cause of blindness among Hispanics over age 40.
Currently, there is no cure for macular degeneration or glaucoma. But if the diseases are found early, they can be treated and managed before vision loss or blindness occurs.
The television, radio, and print spots, available in English and Spanish, urge viewers to visit StopAMD.org and StopGlaucoma.org to learn more about risk factors, diagnosis, and tips for healthy vision.
BrightFocus Foundation is at the forefront of brain and eye health, advancing early-stage, investigator-initiated research around the world. Since its founding more than 50 years ago, BrightFocus and its flagship programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—have invested more than $300 million in research grants to scientists, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools.
Our generous, growing community of donors fuels the drive and brilliance of scientists working around the world to save mind and sight. Learn more at brightfocus.org.
Contact
Julia S. Roth, Sr. Director, Integrated Marketing and Communications
(301) 556-9382
jroth@brightfocus.org
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Since its inception more than 50 years ago, BrightFocus and its flagship research programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—has awarded more than $300 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools. We also share the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
BrightFocus is proudly supporting 186 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
BrightFocus Foundation’s 2025 annual report celebrates groundbreaking research and public awareness.
Jimmy Liu, PhD, has joined BrightFocus as Director of Vision Science Programs, bringing deep expertise in eye disease research and a passion for advancing the next generation of vision treatments.
The proposed 2026 federal budget released by the Trump administration would deliver crippling cuts to the National Institutes of Health (NIH). These cuts would threaten essential progress in the fight against Alzheimer’s disease, macular degeneration, and glaucoma—diseases of mind and sight impacting 1 in 7 Americans over age 40.
Donate Now to Fund Critical Research
Your gift today can help drive innovation in Alzheimer's, macular degeneration, and glaucoma research. By donating, you’ll support life-changing research and provide valuable resources for those affected by these devastating diseases. Give now to fuel hope and bring us closer to finding cures.
